This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
Theravance Inc
THRX : NASDAQ : Health Care
$13.97 | %
Today's Range: 13.68 - 14.48
Avg. Daily Volume: 952,800
11/21/14 - 3:59 PM ET

PEER GROUP: Pharmaceuticals

Ticker Company Name Recent
Net Sales
Net Income
THRX THERAVANCE INC 13.34 1539.02 n/m 2.80 -68.38
SGNT SAGENT PHARMACEUTICALS INC 29.72 948.37 70.76 269.53 15.24
DEPO DEPOMED INC 14.78 868.18 11.03 236.37 96.67
BDSI BIODELIVERY SCIENCES INTL 15.33 786.21 n/m 41.55 59.10
TTPH TETRAPHASE PHARMACEUTICALS 23.22 711.88 n/m 7.92 -7.74
NKTR NEKTAR THERAPEUTICS 13.86 1780.19 n/m 212.30 52.82
LCI LANNETT CO INC 48.28 1726.40 18.08 321.33 98.85
AUXL AUXILIUM PHARMA INC 32.35 1650.56 n/m 407.05 -9.00
PBH PRESTIGE BRANDS HOLDINGS 31.51 1643.97 31.83 617.44 -1.09
MDCO MEDICINES CO 24.28 1588.40 n/m 718.41 8.46
HZNP HORIZON PHARMA PLC 12.39 1472.59 n/m 223.19 343.76
The peer group comparison is based on Major Pharmaceuticals companies of comparable size.

Price Earnings Comparison

THRX Ind Avg S&P 500
n/m 30.17 19.78

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs